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Abstract
Background: Numerous papers have been published examining risk factors for revision of primary total hip
arthroplasty (THA), but there have been no comprehensive systematic literature reviews that summarize the most
recent findings across a broad range of potential predictors.
Methods: We performed a PubMed search for papers published between January, 2000 and November, 2010 that
provided data on risk factors for revision of primary THA. We collected data on revision for any reason, as well as on
revision for aseptic loosening, infection, or dislocation. For each risk factor that was examined in at least three
papers, we summarize the number and direction of statistically significant associations reported.
Results: Eighty-six papers were included in our review. Factors found to be associated with revision included
younger age, greater comorbidity, a diagnosis of avascular necrosis (AVN) as compared to osteoarthritis (OA), low
surgeon volume, and larger femoral head size. Male sex was associated with revision due to aseptic loosening and
infection. Longer operating time was associated with revision due to infection. Smaller femoral head size was
associated with revision due to dislocation.
Conclusions: This systematic review of literature published between 2000 and 2010 identified a range of
demographic, clinical, surgical, implant, and provider variables associated with the risk of revision following primary
THA. These findings can inform discussions between surgeons and patients relating to the risks and benefits of
undergoing total hip arthroplasty.
Keywords: Total hip arthroplasty, Revision, Failure, Risk factor, Aseptic loosening, Infection, Dislocation, Systematic
review
Background
Total hip arthroplasty (THA) is a highly successful and
cost-effective intervention for addressing pain and func-
tional deficits in patients with advanced hip disease [1-
3]. Although the results of THA are generally excellent,
some prostheses eventually fail. In many such cases, re-
vision surgery is performed. As a result, revision THA is
often used as a proxy for implant failure. In the US, over
50,000 revision THAs are performed every year at a dir-
ect cost exceeding $1 billion [4]. Due in part to contin-
ued growth in the utilization of primary THA, the
number of revisions may increase substantially in the
coming decades [5].
Long-term population-based studies have documented
rates of THA failure of 1% per year or less, though there
is considerable variation in revision rates among patient
groups defined by factors such as age and sex [6]. Identi-
fying risk factors for arthroplasty failure is challenging
because revision arthroplasty is a relatively infrequent
outcome that often occurs a decade or more after the
primary procedure. Thus, individual studies require large
sample sizes and/or lengthy follow-up periods to detect
statistically and clinically significant differences in the
risk of revision associated with purported risk factors.
Several articles have identified risk factors for revision of
primary THA based on data from registries or individual
centers, and these findings represent a potential wealth
of evidence on the effects of a range of risk factors on
revision of primary THA. However, a systematic review * Correspondence: jnkatz@partners.org
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and identify relevant trends.
Previous systematic reviews on risk factors for failure
of THA have typically focused on specific research ques-
tions such as the impact of anesthesia type, [7] under-
lying diagnosis, [8] or cemented vs. uncemented fixation
[9]. A 2008 review by Santaguida et al. examined the ef-
fect of patient demographic factors on THA outcome
[10]. That review focused on studies published between
1980 and 2001, however, thereby excluding more re-
cently published work that incorporates longer-term fol-
low-up and more contemporary processes of care such
as modern cementing techniques, biomaterials, and re-
habilitation approaches. To the best of our knowledge,
there have been no efforts to aggregate more recent data
on a more comprehensive set of risk factors.
The purpose of this systematic review is to summarize
the published literature on risk factors for revision of
primary THA relating to pre-operative patient demo-
graphic and clinical factors, surgical factors (including
features of the implant), and health care provider char-
acteristics. In addition to overall revision, we examine
risk factors for the three most common indications for
revision: aseptic loosening, infection, and dislocation,
each of which accounts for at least 15% of total revisions
[11-13]. This systematic review may help surgeons more
accurately assess the factors associated with failure of
THA, and may promote fully informed conversations
about the risks and benefits of the procedure between
surgeons and patients considering THA.
Methods
Search strategy
We conducted a PubMed search on November 16, 2010
to identify studies written in English published between
January 1, 2000 and November 1, 2010. We excluded
articles published prior to 2000 to ensure that the stud-
ies considered reflected secular changes that may have
taken place since the only previously published literature
synthesis [10]. We restricted the review to articles pub-
lished in peer-reviewed journals to ensure methodo-
logical oversight. We combined PubMed hip
arthroplasty MeSH Term keywords with search terms
relating to revision and failure risk to produce the fol-
lowing search query:
("Arthroplasty, Replacement, Hip*"[MeSH Major
Topic] OR (total[Title/Abstract] AND hip[Title/
Abstract] AND (arthroplasty[Title/Abstract] OR
replacement[Title/Abstract])) AND ("risk factor" OR
"risk of failure" OR "risk of revision" OR "rate of
failure" OR "rate of revision" OR "revision risk" OR
survival)
We performed three levels of screening to identify
papers for our review. We reviewed the titles in the
search results based on the exclusion criteria outlined in
Table 1. We retrieved and reviewed abstracts for all arti-
cles deemed potentially eligible at the title stage. Articles
that passed the abstract screening were retrieved as full
manuscripts for the final level of screening.
To ensure comparability across studies and generaliz-
ability, we excluded articles describing samples that
included less than 2,500 person-years of follow-up.
Given a revision risk of 1% per year, this criterion
ensures at least 25 ‘events’ (revisions) per study. Simi-
larly, we required a minimum of 25 cases in case–con-
trol studies.
Validation
A second reviewer independently screened random sam-
ples of 200 titles, 100 abstracts, and 40 papers. Any dis-
agreements in the decision of whether to exclude the
titles, abstracts, or papers were adjudicated by the senior
author (JNK). With the exception of one abstract, the se-
nior author’s assessment of exclusions on all screened
items agreed with that of the primary reviewer (JJZP) (the
abstract was found to be ineligible at the paper level).
We performed a second validation analysis on the over-
all screening process, determining agreement on a single
set of 200 papers that passed through all three levels of
screening (title, abstract, paper). Again, disagreements
were adjudicated by the senior author, and here too, the
senior author’s assessment concurred with that of the pri-
mary reviewer. Finally, the senior author abstracted key
data elements on eight eligible papers, blinded to the pri-
mary reviewer’s abstraction, and agreed with the primary
reviewer’s assessment on all elements in all eight papers.
Data abstraction
For articles that were eligible for inclusion, we extracted
information on study design, sample details, and average
follow-up time. We also abstracted data on the particu-
lar revision endpoint being studied (revision for any rea-
son, aseptic loosening, infection, or dislocation), the
specification of the risk factor being examined (e.g. age
dichotomized or defined as a continuous variable), the
effect measures (e.g. risk ratio, odds ratio, difference in
proportion), confidence intervals, and p-values. We
noted instances in which studies indicated in the text
that a particular factor was associated with a risk of revi-
sion and whether the association reached statistical sig-
nificance, even if no quantitative metric was provided.
Analysis
The heterogeneous nature of the studies’ follow-up
times, risk factor specifications, and effect measures pre-
cluded a formal meta-analysis. Instead, we identified all
risk factors that were examined by at least three studies
for a given endpoint and described the number and
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non-overlapping confidence intervals). We recognize
that categorizing studies on the basis of statistical signifi-
cance of the association of interest has many limitations.
For example, this approach does not incorporate the
magnitude of association, potential confounding, or
study quality. However, it does provide a common
framework with which each study can be assessed, pro-
viding a broad snapshot of the state of the literature.
The findings are intended to identify areas of discord-
ance, which should prompt closer examination of the lit-
erature, and of consistency, reflecting findings that
appear to be robust across multiple reports.
For some studies that did not include quantitative
results in the text, we were able to read results from sur-
vival curves presented in figures. In other cases, studies
collected data on risk factors but did not present them in
a format consistent with our analysis. For these papers,
we used the reported frequencies of exposure and revi-
sion to compute crude relative risk estimates, along with
95% confidence intervals and p-values. In two instances
[13,14], un-stratified frequencies were not reported in
the published paper, so we obtained the data from the
corresponding author. Statistical analyses were per-
formed using SAS software, Version 9.2 of the SAS Sys-
tem for Windows. (SAS Institute Inc., Cary, NC, USA.)
Results
Screening results
Full search results are represented in Figure 1. Of 2,122
titles identified by our search, we included 86 papers in
this review. Of those 86 papers, 65 examined risk factors
for revision for any reason, 30 examined risk factors for
aseptic loosening, nineteen for infection and twelve for
dislocation. In addition, three papers examined unique
endpoints: revision for acetabular osteolysis, revision
within 90 days of primary THA, and revision for any
reason other than infection (which conflates aseptic
loosening and dislocation). These papers were not
included in the analysis. The full abstraction of study de-
sign features and quantitative results on all 86 publica-
tions is available upon request. Frequencies for specific
risk factors by endpoint are presented in Table 2. Refer-
ence numbers for the papers examining each risk factor
for each endpoint are provided in Table 3.
We summarize the data on risk factors that were
examined in at least three papers for at least one end-
point in Table 4. Specifically, we indicate the number of
papers that found a statistically significant increased or
decreased risk and the number of papers that found no
significant association. Risk factors examined by at least
three papers for which no significant associations were
reported are not discussed in the text, but are included
in Table 4.
In order to present a consistent assessment, we
required at least three papers to address the same pair-
wise comparison to meet inclusion for Table 4. Several
underlying diagnoses met this threshold for at least one
comparison. Almost all of these comparisons used OA
as the reference group, so where possible, pairwise com-
parisons among the other diagnoses were performed
using the statistical method outlined above.
Revision for any reason
Demographic and clinical factors
Age Of the 26 papers [1,13-37] that examined age at
primary THA as a risk factor for revision for any reason,
Table 1 Exclusion criteria for the title, abstract, and paper-level screening of articles retrieved from the PubMed search
Exclusion criteria, listed in hierarchical order Example or explanation
￿ Focus on wrong procedure e.g. total knee arthroplasty
￿ Focus on risk factors for primary THA as opposed to risk of revision of THA
￿ Focus on outcomes of revision THA surgery as opposed to risk of revision of primary THA
￿ No living human subjects e.g. canine or simulation study
￿ Focus on non-standard THA e.g. hip resurfacing
￿ Focus on THA to address hip fracture as opposed to THA for hip arthritis
￿ Focus on non-prosthesis THA outcome e.g. mortality
￿ Focus on prosthesis-related non-revision outcome e.g. polyethylene wear
￿ Focus on stem or cup failure only* as opposed to revision of any component
￿ Focus on specific brand comparison only
+ no other comparisons reported
￿ Sample has less than 2,500 person-years at the title level, case studies were excluded
￿ Study includes no new clinical data* e.g. literature review
￿ Study does not report a comparative risk metric
+ e.g. no odds ratio or multiple survival curves
￿ Article could not be retrieved
+ not available in electronic or print archives
* Assessed at the abstract and paper levels of screening only.
+ Assessed at the paper level of screening only.
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with revision risk. Fifteen reported an increased risk of
revision for younger patients, irrespective of the particu-
lar age categories examined (categories ranged from ≤40
to ≥85). The risk of revision generally decreased per
additional decade of age. Two studies reported a statisti-
cally significant increased risk of revision for older
patients.
Sex Eight of the eighteen papers [13,18-22,27,29,31-
35,37,50-53] that evaluated the association of sex with
risk of revision reported a statistically significant associ-
ation. Seven reported an increased risk for men and one
study (6%) reported an increased risk of revision for
women.
Comorbidity (Charlson score) All five papers [27,29,
33-35] that examined comorbidities found a statistically
significant higher risk of revision for a higher Charlson
comorbidity score.
Underlying Diagnosis
Rheumatoid arthritis (RA) vs. osteoarthritis (OA) Of
the nine papers [13,21,27,37,47,61-64] that compared RA
and OA patients who underwent THA, three reported a
statistically significant increased revision risk for RA.
Avascular necrosis (AVN) vs. OA Eight papers
[13,14,18,27,47,53,61,65] compared patients with AVN
and OA, six of which reported a statistically significant
association. Five papers reported an increased risk for
AVN patients and one paper found a decreased risk for
AVN patients.
RA vs. AVN No statistically significant associations were
reported in the four papers [13,27,47,61] that compared
the revision risks in subjects with RA and AVN. Hailer
et al. [13] reported an increased risk for AVN patients in
their adjusted results, but we were unable to establish the
statistical significance of this comparison. The papers com-
paring RA with AVN did not indicate whether the cases of
AVN might have been accompanied by secondary OA.
Surgical and implant-related factors
Uncemented vs. cemented fixation Of the ten papers
[13,17,19,25,26,52,80-83] that considered uncemented
vs. cemented fixation, seven reported a statistically sig-
nificant association with revision risk. Five papers
reported a statistically significant increased risk for unce-
mented prostheses and two found a significant increased
risk of revision for cemented prostheses.
Hybrid vs. cemented fixation Four papers [25,26,52,82]
compared hybrid (cemented stem and uncemented cup)
and fully cemented fixation, and two of them found a
statistically significant increased risk of revision for hy-
brid THA.
Hybrid vs. uncemented fixation Of the four papers
[25,26,52,82] comparing hybrid (cemented stem and
uncemented cup) and fully uncemented fixation, three
papers reported a statistically significant association.
Two papers found an increased risk of revision for unce-
mented prostheses and one found an increased risk for
hybrid prostheses.
Femoral head size Two of the three papers [50,51,84]
examining femoral head size found a statistically
Figure 1 Manuscript search and selection process.
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Specific endpoint Revision (any) Aseptic loosening Infection Dislocation
Total for each endpoint* 65 30 19 12
Risk Factor N^ (%)
+ N (%) N (%) N (%)
Demographic Factors
Age 26 (40%) 12 (40%) 5 (26%) 4 (33%)
Sex 18 (28%) 10 (33%) 6 (32%) 2 (17%)
BMI/body weight 5 (8%) 2 (7%) 2 (11%) 1 (8%)
Race 1 (2%) — 1 (5%) —
Socioeconomic status 1 (2%) — 1 (5%) —
Tobacco use — 1 (3%) ——
Alcohol use —— 1 (5%) —
Preparation of living aids — 1 (3%) ——
Clinical Factors
Underlying diagnosis 21 (32%) 8 (27%) 6 (32%) 3 (25%)
Comorbidity (Charlson) 5 (8%) — 2 (11%) —
Diabetes 1 (2%) 1 (3%) 2 (11%) 1 (8%)
Medication use 3 (5%) 4 (13%) 3 (16%) 3 (25%)
Bilateral vs. unilateral THA 3 (5%) —— —
Genetic predisposition — 1 (3%) 2 (11%) —
Prior hip surgery 1 (2%) 1 (3%) 1 (5%) —
Post-THA childbirth 1 (2%) —— —
Surgical and Implant-Related Factors
Fixation 11 (17%) 6 (20%) 6 (32%) 2 (17%)
Femoral head size 3 (5%) 2 (7%) — 3 (25%)
Bearing 1 (2%) 1 (3%) — 1 (8%)
Coating 1 (2%) 1 (3%) ——
Femoral head material 1 (2%) —— —
Other design-related factors 1 (2%) 2 (7%) 1 (5%) —
Operating time 2 (3%) 1 (3%) 4 (21%) 2 (17%)
Surgical approach 1 (2%) 1 (3%) 1 (5%) 3 (25%)
Ventilation 1 (2%) — 2 (11%) —
Anesthesia —— 2 (11%) —
Infection prophylaxis 1 (2%) 1 (3%) 1 (5%) —
Fixation technique 1 (2%) 1 (3%) ——
Units blood transfused —— 1 (5%) —
Health Care Provider-Related Factors
Hospital volume 6 (9%) 1 (3%) ——
Hospital teaching status 2 (3%) — 1 (5%) —
Rural vs. urban hospital —— 1 (5%) —
Surgeon volume 4 (6%) —— —
Surgeon experience 2 (3%) —— —
* Papers that reported on multiple endpoints are included in each of the relevant columns.
^ — indicates no papers examined the risk factor for that endpoint.
+ Column percentages, not mutually exclusive.
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larger head size. In both studies, 28mm heads were the
largest head size examined.
Health care provider-related factors
Hospital volume Six papers [20,21,35,37,91,92] reported
on the association of hospital volume with revision. One
study found a statistically significant increased risk for
low-volume hospitals.
Surgeon volume Of the four papers [26,29,35,92] that
considered surgeon volume, three found a statistically
significant increased risk of revision for low-volume
surgeons.
Table 3 Reference numbers for papers examining each risk factor for each endpoint
Risk factor Reference numbers for papers
Revision (any) Aseptic loosening Infection Dislocation
Demographic Factors
Age [1,13-37][ 1,13,16,17,19,20,28,38-42][ 13,43-46][ 26,47-49]
Sex [13,18-22,27,29,31-35,37,50-53][ 1,13,17,19,20,28,38,40-42][ 13,43-46,54][ 47,48]
BMI/body weight [55-59][ 39,55][ 44,57][ 57]
Race [34] — [45] —
Socioeconomic status [15] — [45] —
Tobacco use — [60] ——
Alcohol use —— [44] —
Preparation of living aids — [40] ——
Clinical Factors
Underlying diagnosis [13,14,16,18,21,27,31,35,37,47,51,53,61-69][ 1,13,16,28,38,40,64,69][ 13,43,44,46,54,61][ 47,48,61]
Comorbidity (Charlson) [27,29,33-35] — [45,70] —
Diabetes [70][ 70][ 44,70][ 70]
Medication use [68,71,72][ 60,68,71,72][ 68,71,72][ 68,71,72]
Bilateral vs. unilateral THA [73-75] —— —
Genetic predisposition — [76][ 77,78] —
Prior hip surgery [18][ 28][ 46] —
Post-THA childbirth [79] —— —
Surgical and Implant-Related Factors
Fixation [13,17,19,25,26,52,61,80-83][ 13,17,19,81-83][ 13,26,43,46,81,83][ 47,83]
Femoral head size [50,51,84][ 41,42] — [47-49]
Bearing [85][ 86] — [49]
Coating [19][ 19] ——
Femoral head material [51] —— —
Other design-related factors [87][ 87,88][ 43] —
Operating time [33,83][ 83][ 43,45,46,83][ 48,83]
Surgical approach [11][ 11][ 11][ 11,26,48]
Ventilation [89] — [43,46] —
Anesthesia —— [44,46] —
Infection prophylaxis [89][ 89][ 89] —
Fixation technique [90][ 90] ——
Units blood transfused —— [44] —
Health Care Provider-Related Factors
Hospital volume [20,21,35,37,91,92][ 20] ——
Hospital teaching status [21,35] — [45] —
Rural vs. urban hospital —— [45] —
Surgeon volume [26,29,35,92] —— —
Surgeon experience [21,93] —— —
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Demographic and Clinical Factors
Age Of the twelve papers [1,13,16,17,19,20,28,55-59]
that evaluated the association of age at primary THA
with the risk of revision for aseptic loosening, eight
papers reported a statistically significant increased risk
for younger patients. While these studies used different
age stratifications, they consistently found higher risk in
younger patients.
Sex Ten papers [1,13,17,19,20,28,55,57-59] considered
the association of sex with revision for aseptic loosening,
and six papers reported a statistically significant associ-
ation. Five papers reported an increased risk for men and
one paper found an increased risk for women.
Underlying diagnosis
RA vs. OA Three papers [1,13,64] compared the risk of
revision for aseptic loosening for patients with RA and
OA, and one paper found a statistically significant
increased risk for OA patients.
Surgical and implant-related factors
Uncemented vs. cemented fixation All six papers
[13,17,19,81-83] reporting on fixation found statisti-
cally significant associations with risk of revision
for aseptic loosening. Three papers found an in-
creased risk for fully uncemented prostheses and the
other three found an increased risk for cemented
prostheses.
Table 4 Comparison of risk factors for revision for all endpoints addressed by at least three studies
Risk factor Studies reporting on a risk factor for each endpoint: total number, number reporting a statistically
significant (p≤.05) increased (+) or decreased (—) risk of revision, and number with no significant
association (p>.05)
Revision (any) Aseptic loosening Infection Dislocation
Np ≤.05 p>.05 N p≤.05 p>.05 N p≤.05 p>.05 N p≤.05 p>.05
+ — + — + — + —
Demographic and Clinical Factors
Young age 26: 15 2 9 12: 804 5: 005 4: 02 2
Male sex 18: 711 0 10: 514 6: 501 —
Higher BMI/weight 5: 005 ———
Higher Charlson score 5: 500 ———
Underlying Diagnosis
RA (vs. OA) 9: 306 3: 012 6: 105 3: 10 2
AVN (vs. OA) 8: 512 — 3: 102 —
RA (vs. AVN) 4: 004 — 3: 003 —
DDH (vs. RA) —— — 3: — 03
Surgical and Implant-Related Factors
Uncemented (vs. cem) 10: 523 6: 330 4: 013 —
Hybrid (vs. cem) 4: 202 ———
Hybrid (vs. uncem) 4: 121 ———
Larger femoral head 3: 201 —— 3: 03 0
Uncem (vs. cem AL)* —— 3: 102 —
Cem NA (vs. uncem) —— 3: 300 —
Cem NA (vs. cem AL) —— 3: 300 —
Longer operating time —— 4: 301 —
Posterior surgical approach (vs. lateral) —— — 3: 20 1
Health Care Provider-Related Factors
Lower hospital volume 6: 105 ———
Lower surgeon volume 4: 301 ———
* Cem AL = antibiotic-loaded cement.
Cem NA = cement not containing antibiotics.
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Demographic and Clinical Factors
Sex Five of the six papers [13,43-46,54] that examined
sex as a risk factor for revision for infection found a sta-
tistically significant increased risk for men.
Underlying Diagnosis
RA vs. OA Six papers [13,43,44,46,54,61] compared the
risk of revision for infection for patients with RA and
OA (including two papers that compared OA and “in-
flammatory arthritis”), one of which found a statistically
significant increased risk for patients with RA.
AVN vs. OA Of the three papers [13,44,46] that com-
pared patients with AVN and OA for risk of revision
due to infection, one paper reported a significant
increased risk for AVN.
Surgical and Implant-Related Factors
Uncemented vs. cemented fixation Four papers [13,26,
81,83] reported on uncemented vs. cemented fixation as
a risk factor for revision due to infection. One paper
found a statistically significant increased risk for cemen-
ted fixation.
Uncemented vs. antibiotic-loaded cement Of the three
papers [43,46,81] that compared uncemented prostheses
with those containing antibiotic-loaded cement, one
found a statistically significant increased risk for unce-
mented prostheses.
Uncemented vs cement not containing antibiotics All
three papers [43,46,81] that compared revision risk due
to infection for uncemented prostheses vs. those with
cement not containing antibiotics found a statistically
significant increased risk for cement without antibiotics.
Antibiotic-loaded cement vs. cement not containing
antibiotics All three papers [43,46,81] that compared
the risk of revision for infection between prostheses
cemented with and without antibiotics found a statisti-
cally significant increased risk for cement not containing
antibiotics.
Operating time Of the four papers [43,45,46,83] that
examined operating time as a risk factor for revision due
to infection, three found a statistically significant
increased risk for longer surgeries.
Revision for dislocation
Demographic and Clinical Factors
Age Four papers [26,47-49] examined age at primary
THA as a risk factor for revision due to dislocation, two
of which found a statistically significant increased risk
for older age.
Underlying Diagnosis
RA vs. OA Of the three papers [47,48,61] that compared
the risk of revision for dislocation in patients with RA
and OA, one paper reported a significant increased risk
for patients with RA.
Surgical and Implant-Related Factors
Femoral head size All three papers [47-49] that exam-
ined femoral head size as a risk factor for revision due to
dislocation found a statistically significant increased risk
for smaller head size. In all three studies, head sizes
>28mm were associated with a lower risk than head
sizes ≤28mm.
Posterior vs lateral surgical approach Of the three
papers [11,26,48] that examined the risk of revision for
dislocation associated with the posterior vs. lateral surgi-
cal approach, two found a statistically significant
increased risk for the posterior approach. Of note, the
third study reported that the posterior approach was
associated with a “greater early risk of dislocation,” but
that the failure rates for the two approaches evened out
later on in the seven-year follow-up period [26].
Discussion
We conducted a systematic literature review on risk fac-
tors for revision of primary THA relating to the charac-
teristics of the patient, surgery, implant, and health care
provider. We focused on papers published since the year
2000 in order to provide the most up-to-date findings.
We present information on risk factors studied in at
least three papers for one of our endpoints of interest:
revision for any reason or for an indication of aseptic
loosening, infection, or dislocation.
The potential risk factors that were studied by at least
three papers for several endpoints were patient age and
sex, underlying diagnosis, and implant fixation (cemen-
ted vs. uncemented). Younger age at the time of primary
THA was generally associated with a higher risk of over-
all revision and revision for aseptic loosening, but
younger age was also associated with a lower risk of dis-
location. Male sex was generally associated with a higher
risk of revision for aseptic loosening and infection, and
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overall revision.
Our findings with regard to fixation were inconclusive.
Consistent with prior reviews, [6,9] we found a trend to-
ward an increased revision risk for fully uncemented
prostheses: often studies that examined fixation as a risk
factor for overall revision, five found a statistically sig-
nificant increased risk for uncemented prostheses, two
found a statistically significant increased risk for cemen-
ted prostheses, and three reported no significant associa-
tions. A review by Morshed et al. [9] suggests that the
performance of fully uncemented implants may be im-
proving over time as compared with cemented implants.
Our findings suggest the opposite: among papers
included in this review, the two that found an increased
risk for cemented implants examined primary THAs
implanted in the 1980s and early 1990s, while studies fo-
cusing on more recently implanted THAs found a
higher revision risk for fully uncemented implants. This
discrepancy may be due to the fact that nine of the 20
papers in the Morshed review were published prior to
2000 and were therefore excluded from our initial search
query. Many of the rest were ineligible for this review
because they had small sample sizes or examined failure
of a specific component rather than revision of any
component.
There were other notable findings concerning risk fac-
tors for specific endpoints as well. Greater comorbidity
and low surgeon volume were both associated with a
higher risk of overall revision, as was a diagnosis of AVN
as compared to OA. Longer operating time was asso-
ciated with a higher risk of revision for infection. Smaller
femoral head size was associated with an increased risk
for dislocation.
The results of this review indicate that factors may in-
crease the risk of revision for certain endpoints but be
protective for others. For example, younger age was gen-
erally associated with an increased risk of revision for
aseptic loosening and for overall revision, but seemed to
reduce the risk of dislocation. Similarly, smaller femoral
head size increased the risk of dislocation, but may also
be associated with a decreased risk of overall revision. In
cases where a given risk factor works in different direc-
tions for the specific indications, we might expect less
clarity and uniformity with regard to overall revision.
Several challenges and limitations of our review bear
comment and suggest avenues for further work. The
studies in our review examined revision surgery as an
endpoint, but revision rates do not capture failed
implants that are not surgically revised. Focusing on re-
vision misses patients with painful prostheses who do
not seek medical attention, who choose not to have revi-
sion, or who are not offered revision because their gen-
eral health makes them unsuitable surgical candidates.
Thus, revision is a specific but insensitive marker of
THA failure. Validation studies on the Swedish Register
have indicated that clinical failure rates at ten years, as
defined by radiographic loosening in combination with
the Harris Hip Score and the Western Ontario and
McMaster Osteoarthritis Index (WOMAC), are at least
twice as high as the revision rates reported by the Regis-
ter [3,94,95].
With the exception of case–control studies, we limited
our review to large studies with at least 2,500 person-
years of follow-up to enhance the generalizability of our
findings and the stability of the estimates from the
included studied. Eleven case–control studies were
included in the review, but only two reported on risk
factors that were included in Table 4. Approximately half
the papers included in our review were retrospective
analyses of data collected in population-based registries.
This may account for the relative paucity of studies
reporting on factors that are less commonly tracked in
registries, such as socioeconomic status, genetic factors,
functional status, and features of the operating room.
This observation underscores the value of comprehen-
sive arthroplasty registries for research purposes, above
and beyond their role in identifying prostheses or patient
populations with unusually high rates of failure or com-
plications [96,97].
In addition to the person-years exclusion of smaller
cohort studies or studies with shorter follow-up, our
results may have been influenced by publication bias
favoring statistically significant results. We are only able
to summarize the data that authors chose to include in
their published papers, and although some authors re-
port all the results of their analyses, others may choose
to report only those findings they consider most inter-
esting or relevant.
The use of statistical significance as a binary outcome
represents another potential limitation. Statistical signifi-
cance cut-offs are inherently arbitrary, and though they
can provide a useful guide for identifying consistent pat-
terns, they are directly tied to sample size and duration
of follow-up [98]. Table 4 allows us to see risk factors
with a clear signal across papers, but without also con-
sidering the range of reported effect sizes, we cannot de-
termine if the increased or decreased risk is clinically
meaningful.
Due to the large number and variety of papers and po-
tential risk factors examined in this review, we were un-
able to score each study for methodological quality,
contrast design features, or compare quantitative results.
Listing a tally of positive, negative, and non-statistically
significant associations is “rough justice” with respect to
any particular factor, but it can serve as a guide to the
overall state of research on revision of THA. This review
provides a comprehensive picture of what has and has
Prokopetz et al. BMC Musculoskeletal Disorders 2012, 13:251 Page 9 of 13
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sense of whether the findings have been concordant
across studies. Researchers may find it helpful to see
what has already been done, and where there are oppor-
tunities for further work to deepen or clarify our under-
standing of certain issues.
Finally, we call attention to the importance of adjust-
ing for potential confounders. In some of the studies in
this review, the unadjusted and adjusted results for cer-
tain risk factors produced statistically significant associa-
tions in opposite directions due the presence of
confounding factors [13]. For example, patients with
high BMI undergoing THA tend to be younger than the
average patient, so a failure to adjust for the effect of
young age could result in an inflated risk estimate for
BMI. In this review, we abstracted and reported adjusted
results whenever possible. Many papers provided only
unadjusted results, however, and we were unable to ad-
just for confounders when calculating risk ratios from
raw data.
Conclusions
In this review, factors found to be consistently associated
with revision included younger age, greater comorbidity,
a diagnosis of AVN as compared to OA, low surgeon
volume, and larger femoral head size. Male sex was asso-
ciated with revision due to aseptic loosening and infec-
tion. Longer operating time was associated with revision
due to infection. Smaller femoral head size was asso-
ciated with revision due to dislocation.
These findings may be useful to surgeons and patients
contemplating THA or living with THA as they discuss
the scientific evidence for potential risk factors for revi-
sion. Some important factors, such as prosthesis materi-
als and design, were not addressed by a sufficient
number of papers that met our criteria to be included in
this review, and the results for factors like fixation did
not produce a clear signal. Further research could clarify
the prognostic effect of these factors. We also need more
work to determine the level of agreement between risk
factors for revision of primary THA, as identified in this
review, and risk factors for failure of primary THA, a
more pertinent outcome for patients, but one that is
much more difficult to study.
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